[

covid-19 vaccine trial

]
In January, the US government said it will buy 1.25 million additional doses of Regeneron Pharmaceuticals' Covid-19 antibody cocktail.(AP)

Regeneron to stop giving placebo in Covid-19 drug trial after 'clear efficacy'

Reuters |
PUBLISHED ON FEB 25, 2021 05:45 PM IST
The Regeneron treatment is part of a class of drugs known as monoclonal antibodies.
The vaccine was one of four candidates that Australia had committed to buy and accordingly agreements were made to secure 51 million doses of the experimental vaccine.(REUTERS)
The vaccine was one of four candidates that Australia had committed to buy and accordingly agreements were made to secure 51 million doses of the experimental vaccine.(REUTERS)

Australia ends Covid-19 vaccine trials due to HIV antibody positives

Melbourne | By Press Trust of India| Posted by Susmita Pakrasi
PUBLISHED ON DEC 11, 2020 01:31 PM IST
Following consultation with the Australian Government, UQ and CSL decided not to progress the vaccine candidate to phase 2 and 3 clinical trials.
Human challenge trial will help researchers find which vaccine is the most promising one as there are several vaccines under trial now.(AP)
Human challenge trial will help researchers find which vaccine is the most promising one as there are several vaccines under trial now.(AP)

What is ‘human challenge’ that UK cleared to speed up Covid-19 vaccine trial?

Hindustan Times, New Delhi | By hindustantimes.com | Edited by Poulomi Ghosh
UPDATED ON OCT 21, 2020 08:27 AM IST
Human challenge studies were conducted for cholera, typhoid, malaria, influenza, tuberculosis, dengue etc., in the past
The vaccine developer plans to start the global trial after data from the ongoing studies.(REUTERS)
The vaccine developer plans to start the global trial after data from the ongoing studies.(REUTERS)

CureVac plans global late-stage Covid-19 vaccine trial in fourth quarter

Reuters | By Reuters| Posted by Susmita Pakrasi
PUBLISHED ON SEP 30, 2020 08:11 AM IST
CureVac has dosed the first patient with its experimental Covid-19 vaccine in the trial taking place in Peru and Panama and expects data on older adults in the fourth quarter.
Drugmakers racing to develop a safe and effective coronavirus vaccine pledged in July to ensure their larger clinical trials would include diverse sets of volunteers.(REUTERS)
Drugmakers racing to develop a safe and effective coronavirus vaccine pledged in July to ensure their larger clinical trials would include diverse sets of volunteers.(REUTERS)

Pfizer, BioNTech propose expanding Covid-19 vaccine trial to 44,000 volunteers

Reuters | By Reuters| Posted by Susmita Pakrasi
PUBLISHED ON SEP 13, 2020 10:04 AM IST
The initial target figure for the trial was up to 30,000 participants, which the companies said they expect to reach by next week.
A man walks past a sign at an AstraZeneca site in Macclesfield, central England(REUTERS)
A man walks past a sign at an AstraZeneca site in Macclesfield, central England(REUTERS)

AstraZeneca pauses Covid-19 vaccine trial just after 9 drug makers take safety pledge

Hindustan Times, Washington | By Yashwant Raj
UPDATED ON SEP 09, 2020 10:10 PM IST
The move comes amid a growing perception that despite his claims to the contrary, US President Donald Trump is rushing the search for a vaccine breakthrough before November 3, the election day, to help him win a second term.
Moderna began the study of its vaccine candidate, mRNA-1273, in July and expects to complete enrollment in September.(REUTERS)
Moderna began the study of its vaccine candidate, mRNA-1273, in July and expects to complete enrollment in September.(REUTERS)

Moderna says more than 40% of participants enrolled for Covid-19 vaccine trial

Reuters | By Reuters| Posted by Susmita Pakrasi
PUBLISHED ON AUG 22, 2020 07:21 AM IST
In a tweet, the company also said that 18% of the participants currently enrolled are Black, Latino, American Indian or Alaska Native, groups among the hardest hit by the coronavirus virus pandemic.
SHARE
Story Saved